BioSpace News Archive

Business

Long-time Collaborators Botond Roska and José-Alain Sahel Win International Prize for Translational Neuroscience

In recognition of their pioneering work on restoring vision to blind patients using optogenetic therapy, Botond Roska and José-Alain Sahel were awarded the International Prize for Translational Neuroscience by the Gertrud Reemtsma Foundation, managed by the Max Planck Society.

June 22, 2023
·
4 min read
Drug Development

Madrigal Pharmaceuticals Presents Phase 3 MAESTRO-NASH Data During the Opening General Session of the EASL Congress™

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis, presents resmetirom Phase 3 MAESTRO-NASH data at the opening general session of the European Association for the Study of the Liver Congress.

June 22, 2023
·
15 min read
Business

Encision Reports Fourth Quarter Fiscal Year 2023 Results

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous radiant energy burns in minimally invasive surgery, announced financial results for its fiscal 2023 fourth quarter that ended March 31, 2023.

June 22, 2023
·
6 min read
Zeta Surgical Announces Successful Treatment of First Patient in Neurosurgical Navigation Clinical Trial at Singapore’s National Neuroscience Institute

Zeta Surgical, a surgical robotics and mixed reality company, has successfully treated its first patient using the Zeta Cranial Navigation System as part of their first-in-human trial at Singapore’s National Neuroscience Institute.

June 22, 2023
·
2 min read
Genetown

Ankara Etlik City Hospital is Live on SOPHiA GENETICS Platform

SOPHiA GENETICS announced that Ankara Etlik City Hospital, the largest hospital in the capital city of Turkey, is live on the SOPHiA DDM™ Platform.

June 22, 2023
·
4 min read
Drug Development

IDEAYA Announces First Reported Case of Uveal Melanoma Patient Spared Enucleation in Phase 1 Neoadjuvant IST with Darovasertib Monotherapy

IDEAYA Biosciences, Inc. announced a first reported case of a uveal melanoma patient who was treated with single agent darovasertib as neoadjuvant therapy and was spared enucleation in an Investigator Sponsored Trial.

June 22, 2023
·
5 min read
Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Model to a Board of Directors

ValnevaSE, a specialty vaccine company, announced that its Supervisory Board has recommended a change of governance model.

June 22, 2023
·
3 min read
Hospital La Fe Expands Telehealth Program with Masimo W1™ for Preoperative Patients

Masimo announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced health tracking watch.

June 22, 2023
·
8 min read
Drug Development

Reviva Pharmaceuticals Announces 80% Global Enrollment Update for Pivotal Phase 3 RECOVER Study Evaluating Brilaroxazine for Schizophrenia

Reviva Pharmaceuticals Holdings, Inc. announced over 80% of patients have been enrolled in the pivotal Phase 3 RECOVER study evaluating brilaroxazine for the treatment of schizophrenia.

June 22, 2023
·
6 min read
Biotech Beach

MannKind Launches Inhale-3 Study to Address the Most Important Unmet Need Today in Adults Living With Type 1 Diabetes (T1D)

MannKind Corporation announced that it is launching the INHALE-3 study to address the most important unmet need in adults living with T1D.

June 22, 2023
·
10 min read